Dr. Julien Mamet Ph.D. is the Founder, Chief Scientific Officer & Director at Adynxx.
As the Founder a Chief Scientific Officer & Director of Adynxx, the total compensation of Dr D at Adynxx is $378,466. There are 1 executives at Adynxx getting paid more, with Richard Orr having the highest compensation of $473,589.
Dr D is 45, he's been the Founder a Chief Scientific Officer & Director of Adynxx since . There are 3 older and no younger executives at Adynxx. The oldest executive at Adynxx, Inc. is Dennis Podlesak, 62, who is the Chairman of the Board.
Julien's mailing address filed with the SEC is C/O ADYNXX, INC., 100 PINE ST., STE. 500, SAN FRANCISCO, CA, 94111.
Adynxx, Inc., a clinical stage biopharmaceutical company, focuses on the development and marketing of transcription factor decoy technologies for the treatment of pain and inflammatory diseases. It is involved in the development of AYX platform of transcription factor decoys, including brivoligide, which is in Phase II clinical development for the reduction of postoperative pain; and AYX2, a pre-clinical candidate intended for the treatment of focal chronic pain. The company was founded in 2007 and is headquartered in San Francisco, California.
Adynxx executives and other stock owners filed with the SEC include: